By DAMIEN NOVAK
The AstraZeneca Covid-19 vaccine will have its name changed in Australia, as part of a push to standardise its name across the world and make it easier for those who have received the jab to travel overseas, the company has announced.
AstraZeneca says the new name will be used on vaccine certificates, as well as on vaccine passports, which are expected to be introduced to facilitate international travel.
“We are currently in the process of registering the trade name Vaxzevria, which is used in many other markets including the EU,” the company announced today.
“This will facilitate travel for people who have received AstraZeneca’s vaccine from anywhere in the world.’
The manufacturer stressed the product would remain the same despite the change from the current official name, Covid-19 Vaccine AstraZeneca.
“AstraZeneca’s Covid-19 vaccine is the same product wherever it is made, including at CSL [in Australia],” the company said.
“All manufacturing around the world is conducted using the same stringent manufacturing process, and each batch passes over 60 quality tests as part of our global robust quality assurance process.
“As such the vaccine made by CSL is a valid vaccination for travel.”
In Europe, the brand name Vaxzevria already has European Medicines Agency approval.
Astra Zeneca said more than 750 million doses of the vaccine have been released for supply to 170 countries to date.
In Australia, more than 15.6 million doses have been administered so far.
Despite a much-discussed and potentially fatal rare blood clotting side effect, of the 15.6 million doses, a total of seven people have died in Australia from complications caused by the vaccine.
Current NSW Health advice urges all adults to be vaccinated with whichever vaccine is first available to them, due to the high risk of catching Covid-19 caused by the outbreak of the Delta variant, which began in Bondi in mid-June.
This morning, NSW Premier Gladys Berejiklian announced the worst one-day total to date, revealing that 633 new cases of Covid-19 were transmitted locally in the 24 hours to 8pm last night.
One case acquired internationally was also announced, as well as three deaths: a man in his 60s and two men in their 70s.
At time of writing, 52 per cent of the population of NSW had received at least one dose of a Covid-19 vaccine, while 28 per cent had been fully vaccinated.
Yesterday, the NSW Government announced that more people would become eligible for Pfizer’s Covid-19 vaccine from 9am tomorrow, when Pfizer jabs become available to people aged 16 to 39 in Sydney’s 12 local government “areas of concern”.
The development is part of a “vaccine blitz”, announced by NSW Premier Gladys Berejiklian, using 530,000 Pfizer vaccines secured by the federal government at the weekend.
For official information on Covid-19 vaccination in NSW, including eligibility, vaccination locations and bookings, visit www.nsw.gov.au/covid-19/health-and-wellbeing/covid-19-vaccination-nsw.
- NSW issues new measures to protect communities from Omicron variant
- HIV/AIDS – the neglected pandemic
- “Businesses deserve two votes, not one”: the Liberal candidate for Sydney Lord Mayor
- Potts Point rally to urge restoration of Metro-Minerva Theatre
- The Existential Expert on apartment block awkwardness … and a lazy strata manager
- You’ll kak your pantos laughing